Smith Graham & Co Investment Advisors’s Pediatrix Medical MD Stock Holding History

Smith Graham & Co Investment Advisors’s Portfolio MD Stock Details MD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	$4.97M	Buy	534,621 +181,662	+51%	+$1.88M	0.57%	80
2023 Q3	$4.49M	Sell	352,959 -3,292	-0.9%	-$45.2K	0.56%	85
2023 Q2	$5.06M	Sell	356,251 -15,429	-4%	-$217K	0.61%	71
2023 Q1	$5.54M	Sell	371,680 -1,167	-0.3%	-$17.7K	0.67%	63
2022 Q4	$5.54M	Buy	372,847 +54,256	+17%	+$885K	0.68%	65
2022 Q3	$5.26M	Buy	318,591 +37,924	+14%	+$763K	0.7%	58
2022 Q2	$5.9M	Buy	+280,667	New	+$5.73M	0.73%	54

Other funds holding MD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Smith Graham & Co Investment Advisors's MD Position: Q4 2023 in Review

Smith Graham & Co Investment Advisors increased its Pediatrix Medical (MD) stake by 51% in Q4 2023, buying an estimated $1.88M and bringing the position to 534,621 shares worth $4.97M. The position accounts for 0.57% of the portfolio, ranked #80.

Smith Graham & Co Investment Advisors first reported a position in MD in Q2 2022 and has held it in 7 quarters since. The position peaked at $5.9M in Q2 2022. 223 funds tracked by Wall St. Rank hold MD as of Q4 2023.

Smith Graham & Co Investment Advisors held 534,621 shares of Pediatrix Medical worth $4.97M as of Q4 2023.
Smith Graham & Co Investment Advisors bought 181,662 Pediatrix Medical shares in Q4 2023, an estimated $1.88M.
Pediatrix Medical made up 0.57% of Smith Graham & Co Investment Advisors's portfolio in Q4 2023, its #80 holding.
Smith Graham & Co Investment Advisors first reported a position in Pediatrix Medical in Q2 2022 and has held it in 7 quarters since.
Smith Graham & Co Investment Advisors's Pediatrix Medical position peaked at $5.9M in Q2 2022.
223 funds tracked by Wall St. Rank held Pediatrix Medical as of Q4 2023.

Based on Smith Graham & Co Investment Advisors's 13F filing for Q4 2023, filed 29 Jan 2024.